---
title: "Ascending Aortic Calcium Predicts Risk in Patients with Normal PET Perfusion, Flow and CAC"
id: "medrxiv-18-ascending-aortic-calcium-identifies-patients-at-risk-despite-normal-myocardial"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-18-ascending-aortic-calcium-identifies-patients-at-risk-despite-normal-myocardial"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.09.26365170v1?rss=1"
published_at: "2026-10-12T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Ascending Aortic Calcium Predicts Risk in Patients with Normal PET Perfusion, Flow and CAC
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-18-ascending-aortic-calcium-identifies-patients-at-risk-despite-normal-myocardial
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.09.26365170v1?rss=1)
- **Published At:** 2026-10-12T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The multicenter REFINE-PET registry provided the cohort of 21,923 patients; investigators identified a subset with normal perfusion, normal flow metrics and absent coronary calcium labeled “triple-normal.” - Triple-normal status was defined in the report as stress total perfusion deficit (TPD) 2 and CAC 0; 3,580 patients met that definition (16.3% of the cohort). - Within the triple-normal group, automated **ascending aortic calcification** (**AAC**) was present in 1,322 patients (36.9%); median AAC Agatston score was 65 (IQR 22–212). - The study used deep-learning aortic segmentation on non-contrast attenuation correction CT to compute AAC with Agatston scoring; agreement with three blinded human readers was good to excellent (ICC 0.87–0.90), investigators reported. - Median follow-up was 52 months (IQR 26–69). During follow-up, 194 primary events occurred; the primary composite endpoint comprised cardiovascular death, myocardial infarction or heart failure admission. - Per one standard deviation increase in AAC, adjusted Cox models showed association with the primary endpoint (adjusted HR 1.24; 95% CI 1.09–1.40; p<0.001), heart failure admission (adjusted HR 1.30; 95% CI 1.10–1.55; p=0.003), and all-cause mortality (adjusted HR 1.17; 95% CI 1.04–1.32; p=0.009). - AAC improved multivariable model fit beyond clinical variables, **myocardial flow reserve** and total perfusion deficit (reported p ≤ 0.009), though gains in discrimination were modest (ΔC 0.007–0.009). - The registry investigators noted that AAC provided an outcome signal most pronounced for heart failure admission among patients otherwise deemed low risk by PET metrics. - The authors state that data are available from the corresponding author under registry data-use agreements and IRB approvals; the source did not report detailed per-center acquisition parameters or specific AAC cutoffs for clinical decision thresholds.
## Clinical Analysis & Structured Key Points
Ascending Aortic Calcium Identifies Patients at Risk Despite Normal Myocardial Flow, Perfusion and Coronary Calcium: A 13-Site Cohort Study | medRxiv Skip to main content Ascending Aortic Calcium Identifies Patients at Risk Despite Normal Myocardial Flow, Perfusion and Coronary Calcium: A 13-Site Cohort Study Clemens Spielvogel , Aakash Shanbhag , Shaun Khanna , Tara Zuhair Kassem , Mark Lemley , Jirong Yi , Giselle Ramirez , Paul Kavanagh , Assiata Kamagate , Leandro Slipczuk , Mark I Travin , Ronny R Buechel , Robert A DeKemp , Erick Alexanderson , Isabel Carvajal-Juarez , Rene RS Packard , Mouaz Al-Mallah , Andrew J Einstein , Wanda Acampa , Stacey Knight , Viet T Le , Steve Mason , Thomas L Rosamond , Robert JH Miller , Panithaya Chareonthaitawee , View ORCID Profile Damini Dey , Daniel S Berman , Marcelo F Di Carli , View ORCID Profile Piotr Slomka doi: https://doi.org/10.64898/2026.10.09.26365170 Clemens Spielvogel 1 Cedars-Sinai Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Aakash Shanbhag 1 Cedars-Sinai Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Shaun Khanna 1 Cedars-Sinai Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Tara Zuhair Kassem 1 Cedars-Sinai Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mark Lemley 1 Cedars-Sinai Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jirong Yi 1 Cedars-Sinai Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Giselle Ramirez 1 Cedars-Sinai Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Paul Kavanagh 1 Cedars-Sinai Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Assiata Kamagate 1 Cedars-Sinai Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Leandro Slipczuk 2 Montefiore Medical Center and Albert Einstein College of Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mark I Travin 3 Montefiore Health System/Albert Einstein College of Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ronny R Buechel 4 University Hospital of Zurich; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Robert A DeKemp 5 radekemp{at}ottawaheart.ca; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Erick Alexanderson 6 National Autonomous University of Mexico; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Isabel Carvajal-Juarez 6 National Autonomous University of Mexico; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Rene RS Packard 7 David Geffen School of Medicine, University of California Los Angeles; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mouaz Al-Mallah 8 Houston Methodist Academic Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Andrew J Einstein 9 Columbia University Irving Medical Center and New York-Presbyterian Hospital; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Wanda Acampa 10 University Federico II; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Stacey Knight 11 Intermountain Healthcare; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Viet T Le 11 Intermountain Healthcare; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Steve Mason 11 Intermountain Healthcare; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Thomas L Rosamond 12 The University of Kansas Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Robert JH Miller 13 University of Calgary; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Panithaya Chareonthaitawee 14 Mayo Clinic; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Damini Dey 15 cedars-sinai medical center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Damini Dey Daniel S Berman 1 Cedars-Sinai Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Marcelo F Di Carli 16 Brigham and Women's Hospital Find this author on Google Scholar Find this author on PubMed Search for this author on this site Piotr Slomka 1 Cedars-Sinai Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Piotr Slomka For correspondence: piotr.slomka{at}cshs.org Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background Patients with normal perfusion, normal myocardial flow reserve (MFR) and no coronary artery calcium (CAC) on myocardial perfusion imaging are considered low risk. Yet, adverse events still occur and no routinely reported imaging marker stratifies residual risk. This study aims to determine whether fully automated ascending aortic calcification (AAC) from the attenuation correction CT stratifies risk in these patients. Methods In the multicenter REFINE-PET registry, AAC was quantified from non-contrast CT using deep learning aortic segmentation and Agatston scoring. Triple-normal was defined as stress total perfusion deficit (TPD) 2 and CAC 0. The primary endpoint was cardiovascular death, myocardial infarction or heart failure admission, with heart failure admission as key secondary endpoint. Cox models were adjusted for clinical confounders. Results Of 21,923 patients, 3,580 (16.3%) were triple-normal, of whom 1,322 (36.9%) had AAC (median Agatston 65, IQR 22-212). Agreement with three blinded readers was good to excellent (Intraclass correlation coefficient 0.87-0.90). Over a median follow-up of 52 months (IQR 26-69), 194 primary events occurred. Per standard deviation, AAC was independently associated with the primary endpoint (adjusted HR 1.24, 95% CI 1.09-1.40; p<0.001), heart failure admission (adjusted HR 1.30, 95% CI 1.10-1.55; p=0.003) and all-cause mortality (adjusted HR 1.17, 95% CI 1.04-1.32; p=0.009). AAC improved model fit beyond clinical factors, MFR and TPD (p< or =0.009), with modest gains in discrimination (ΔC 0.007-0.009). Conclusions In patients with normal PET readouts, automated AAC was independently associated with adverse outcomes, most strongly heart failure admission, beyond clinical risk factors, perfusion and flow. Competing Interest Statement CPS declares consulting fees from Pfizer and speaker fees from Pfizer, CMI Experts, the European School of Multimodality Imaging & Therapy (ESMIT), Hermes Medical Solutions and the European Society for Radiology. CPS receives funding from the FWF Austrian Science Fund (10.55776/J4998). RM received consulting fees from Alnylam and Bayer and research support from Alberta Innovates. DB and PS participated in software royalties for QPS software at Cedars-Sinai Medical Center. DB, DD, and PS reported equity in APQ Health Inc. DB received research grant support from The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and consulting fees from GE Healthcare. PS received research grant support from Siemens Medical Systems, and consulting fees from Synektik SA and Novo Nordisk. PC reported consulting for Clario. MDC reported consulting fees from MedTrace, Valo Health, GE, Bitterroot Bio, and IBA, investigator-initiated research support from Amgen, and institutional research grant support from Sun Pharma, Xylocor, Alnylam, and Intellia. AJE has received speaker fees from Ionetix, consulting fees from Artrya and W. L. Gore & Associates, and authorship fees from Wolters Kluwer Healthcare. AJE has also served on scientific advisory boards for Canon Medical Systems and Synektik S.A. and received grants to Columbia University from Alexion, Attralus, BridgeBio, Canon Medical Systems, Eidos Therapeutics, Intellia Therapeutics, International Atomic Energy Agency, Ionis Pharmaceuticals, National Institutes of Health, Neovasc, Pfizer, Roche Medical Systems, Shockwave Medical, and W. L. Gore & Associates. RRSP serves as a consultant for GE HealthCare. MA-M received research support from Siemens and GE Healthcare and is a consultant to Jubilant, Medtrace, GE Healthcare, and Pfizer. LS received grant support/consulting honorarium from Amgen and Philips and served as site PI for V-INITIATE and Ocean(a) trials. VTL has received research grant support from J&J/Janssen, has received honorarium from the American College of Cardiology for Editor-in-Chief role at Cardiosmart, and has served on advisory boards for Amgen, Amarin, Bayer, Boehringer Ingelheim, Esperion, Idorsia, iRhythm, Merck, Novartis, Novo Nordisk, and Pfizer. The remaining authors have nothing to declare. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The investigators ensured that the institutional ethics committee at each center evaluated and approved the study protocol before data collection and transfer. The overall registries were approved by the Institutional Review Board (IRB) at Cedars-Sinai Medical Center (Office of Research Compliance and Quality Improvement). Sites either obtained written informed consent or the requirement for written informed consent was waived for this retrospective analysis of clinically acquired imaging. This study was conducted in accordance with the Declaration of Helsinki and approved by the institutional review boards at each participating site. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The data that support the findings of this study are available from the corresponding author upon reasonable request, subject to the data use agreements governing the REFINE PET registry and to institutional review board approval at the contributing sites. Funder Information Declared FWF Austrian Science Fund, https://ror.org/013tf3c58 National Heart, Lung, and Blood Institute , R35HL161195 , National Institute of Biomedical Imaging and Bioengineering , R01EB034586 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted October 12, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Ascending Aortic Calcium Identifies Patients at Risk Despite Normal Myocardial Flow, Perfusion and Coronary Calcium: A 13-Site Cohort Study Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Ascending Aortic Calcium Identifies Patients at Risk Despite Normal Myocardial Flow, Perfusion and Coronary Calcium: A 13-Site Cohort Study Clemens Spielvogel , Aakash Shanbhag , Shaun Khanna , Tara Zuhair Kassem , Mark Lemley , Jirong Yi , Giselle Ramirez , Paul Kavanagh , Assiata Kamagate , Leandro Slipczuk , Mark I Travin , Ronny R Buechel , Robert A DeKemp , Erick Alexanderson , Isabel Carvajal-Juarez , Rene RS Packard , Mouaz Al-Mallah , Andrew J Einstein , Wanda Acampa , Stacey Knight , Viet T Le , Steve Mason , Thomas L Rosamond , Robert JH Miller , Panithaya Chareonthaitawee , Damini Dey , Daniel S Berman , Marcelo F Di Carli , Piotr Slomka medRxiv 2026.10.09.26365170; doi: https://doi.org/10.64898/2026.10.09.26365170 Share This Article: Copy Citation Tools Ascending Aortic Calcium Identifies Patients at Risk Despite Normal Myocardial Flow, Perfusion and Coronary Calcium: A 13-Site Cohort Study Clemens Spielvogel , Aakash Shanbhag , Shaun Khanna , Tara Zuhair Kassem , Mark Lemley , Jirong Yi , Giselle Ramirez , Paul Kavanagh , Assiata Kamagate , Leandro Slipczuk , Mark I Travin , Ronny R Buechel , Robert A DeKemp , Erick Alexanderson , Isabel Carvajal-Juarez , Rene RS Packard , Mouaz Al-Mallah , Andrew J Einstein , Wanda Acampa , Stacey Knight , Viet T Le , Steve Mason , Thomas L Rosamond , Robert JH Miller , Panithaya Chareonthaitawee , Damini Dey , Daniel S Berman , Marcelo F Di Carli , Piotr Slomka medRxiv 2026.10.09.26365170; doi: https://doi.org/10.64898/2026.10.09.26365170 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (627) Allergy and Immunology (914) Anesthesia (341) Cardiovascular Medicine (4904) Dentistry and Oral Medicine (487) Dermatology (421) Emergency Medicine (665) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1652) Epidemiology (16105) Forensic Medicine (35) Gastroenterology (1222) Genetic and Genomic Medicine (7151) Geriatric Medicine (740) Health Economics (1079) Health Informatics (5164) Health Policy (1450) Health Systems and Quality Improvement (1801) Hematology (594) HIV/AIDS (1361) Infectious Diseases (except HIV/AIDS) (16385) Intensive Care and Critical Care Medicine (1186) Medical Education (682) Medical Ethics (156) Nephrology (731) Neurology (7423) Nursing (372) Nutrition (1106) Obstetrics and Gynecology (1270) Occupational and Environmental Health (1015) Oncology (3674) Ophthalmology (1074) Orthopedics (399) Otolaryngology (460) Pain Medicine (486) Palliative Medicine (142) Pathology (714) Pediatrics (1829) Pharmacology and Therapeutics (742) Primary Care Research (780) Psychiatry and Clinical Psychology (6017) Public and Global Health (9868) Radiology and Imaging (2472) Rehabilitation Medicine and Physical Therapy (1488) Respiratory Medicine (1257) Rheumatology (653) Sexual and Reproductive Health (791) Sports Medicine (590) Surgery (790) Toxicology (108) Transplantation (313) Urology (299)
## Related Clinical Research

- [Psychosocial profile in adults with congenital heart disease by documented anxiety disorder history](https://medichelpline.com/clinical-feed/plos-one-21-psychosocial-profile-of-adults-with-congenital-heart-disease-according-to.md)
- [Cardiovascular risk prediction models in women: protocol for an updated systematic review](https://medichelpline.com/clinical-feed/plos-one-7-cardiovascular-risk-prediction-models-for-women-a-systematic-review-protocol.md)
- [Plethysmometry: automated cuff method to estimate systolic, diastolic and mean arterial pressure r](https://medichelpline.com/clinical-feed/medrxiv-4-plethysmometry-an-automated-cuff-based-method-for-estimating-ranges-of-systolic.md)
- [Quality of Life, Utilization, and Spending in US Adults with Myocardial Infarction and Heart Failu](https://medichelpline.com/clinical-feed/medrxiv-3-health-related-quality-of-life-healthcare-utilization-and-expenditure-in-us.md)
- [Long-term cardiovascular risk after assisted reproductive technology and infertility: nationwide c](https://medichelpline.com/clinical-feed/plos-medicine-0-long-term-risk-of-cardiovascular-disease-after-assisted-reproductive-technology.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.